Skip to content

Walter Cabri

  • VP API I&D
  • VP API I&D
  • Fresenius Kabi Oncology Limited
  • 27h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 3372CitationsNumber of citations received by Walter's publications. Updated daily.

Other IDs

Co-authors (298)

  • Marco Pierini

Publications (5)

  • Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A<inf>2A</inf> Receptor Ligands

    • Pace S
    • Brogin G
    • Stasi M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A<inf>2A</inf> Receptor Ligands

    • Pace S
    • Brogin G
    • Stasi M
    • et al.
    N/AReaders
    1Citations
    Get full text
  • Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold

    • Taddei M
    • Ferrini S
    • Giannotti L
    • et al.
    N/AReaders
    30Citations
    Get full text
  • Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases

    • Butini S
    • Brindisi M
    • Gemma S
    • et al.
    N/AReaders
    13Citations
    Get full text
  • Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90

    • Baruchello R
    • Simoni D
    • Grisolia G
    • et al.
    N/AReaders
    22Citations
    Get full text

Professional experience

VP API I&D

Fresenius Kabi Oncology Limited

June 2014 - Present

Education

PhD

University of Montreal School of Criminology

January 1989 - January 1990(a year)

Soecialized School in Chemistry

Politecnico di Milano Dipartimento di Chimica Materiali e Ingegneria Chimica Giulio Natta

January 1985 - January 1987(2 years)

Doctor in Chemistry

Universita degli Studi di Milano

January 1978 - January 1985(7 years)